Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 30 | 2019 | 61 | 8.930 |
Why?
|
| Nicotine | 13 | 2019 | 164 | 2.960 |
Why?
|
| Ventral Tegmental Area | 7 | 2019 | 35 | 2.940 |
Why?
|
| Neurons | 14 | 2019 | 486 | 2.910 |
Why?
|
| Habenula | 5 | 2019 | 6 | 2.150 |
Why?
|
| Dopamine | 9 | 2017 | 262 | 1.740 |
Why?
|
| Mice | 30 | 2019 | 2571 | 1.570 |
Why?
|
| Synaptic Transmission | 5 | 2019 | 124 | 1.380 |
Why?
|
| Nicotinic Agonists | 6 | 2019 | 39 | 1.330 |
Why?
|
| Animals | 38 | 2019 | 8196 | 1.180 |
Why?
|
| Glutamic Acid | 2 | 2019 | 50 | 1.130 |
Why?
|
| Brain | 7 | 2019 | 966 | 1.010 |
Why?
|
| Tobacco Use Disorder | 3 | 2019 | 90 | 0.910 |
Why?
|
| Mice, Inbred C57BL | 9 | 2018 | 792 | 0.860 |
Why?
|
| Receptors, AMPA | 2 | 2014 | 16 | 0.830 |
Why?
|
| Mice, Transgenic | 11 | 2018 | 257 | 0.830 |
Why?
|
| Nicotinic Antagonists | 4 | 2017 | 17 | 0.770 |
Why?
|
| Neural Pathways | 2 | 2019 | 112 | 0.710 |
Why?
|
| Reward | 3 | 2017 | 64 | 0.700 |
Why?
|
| Motor Activity | 2 | 2015 | 332 | 0.680 |
Why?
|
| Acetylcholine | 2 | 2019 | 69 | 0.680 |
Why?
|
| Mutation | 6 | 2015 | 497 | 0.590 |
Why?
|
| Photolysis | 1 | 2019 | 4 | 0.590 |
Why?
|
| Lasers | 1 | 2019 | 22 | 0.580 |
Why?
|
| Genetic Vectors | 2 | 2018 | 108 | 0.560 |
Why?
|
| Membrane Potentials | 2 | 2017 | 76 | 0.550 |
Why?
|
| Cell Membrane | 3 | 2011 | 109 | 0.540 |
Why?
|
| Ibogaine | 1 | 2017 | 3 | 0.540 |
Why?
|
| RGS Proteins | 3 | 2007 | 13 | 0.530 |
Why?
|
| Patch-Clamp Techniques | 7 | 2019 | 76 | 0.500 |
Why?
|
| GTP-Binding Protein beta Subunits | 2 | 2006 | 2 | 0.470 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 84 | 0.460 |
Why?
|
| Protein Subunits | 5 | 2014 | 40 | 0.430 |
Why?
|
| Corpus Striatum | 2 | 2011 | 69 | 0.400 |
Why?
|
| Gene Expression | 1 | 2014 | 346 | 0.390 |
Why?
|
| Ethanol | 1 | 2014 | 195 | 0.370 |
Why?
|
| Visual Pathways | 1 | 2012 | 42 | 0.370 |
Why?
|
| Synapses | 1 | 2012 | 87 | 0.350 |
Why?
|
| Superior Colliculi | 1 | 2012 | 121 | 0.340 |
Why?
|
| Locomotion | 1 | 2010 | 34 | 0.320 |
Why?
|
| Male | 11 | 2019 | 19437 | 0.320 |
Why?
|
| Mice, Knockout | 5 | 2017 | 454 | 0.310 |
Why?
|
| Mesencephalon | 2 | 2010 | 21 | 0.300 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2003 | 16 | 0.300 |
Why?
|
| Cell Nucleus | 2 | 2006 | 111 | 0.270 |
Why?
|
| Subcellular Fractions | 1 | 2007 | 15 | 0.270 |
Why?
|
| Membrane Proteins | 2 | 2006 | 243 | 0.260 |
Why?
|
| Organ Culture Techniques | 2 | 2018 | 44 | 0.250 |
Why?
|
| Hyperkinesis | 3 | 2011 | 8 | 0.250 |
Why?
|
| Female | 8 | 2019 | 19943 | 0.240 |
Why?
|
| Carrier Proteins | 2 | 2003 | 145 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 124 | 0.230 |
Why?
|
| Endoplasmic Reticulum | 2 | 2011 | 24 | 0.220 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2003 | 1 | 0.200 |
Why?
|
| Golgi Apparatus | 1 | 2003 | 10 | 0.200 |
Why?
|
| Protein Kinases | 1 | 2003 | 34 | 0.200 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 70 | 0.190 |
Why?
|
| Synaptosomes | 3 | 2011 | 17 | 0.190 |
Why?
|
| Neostriatum | 2 | 2013 | 28 | 0.180 |
Why?
|
| Long-Term Potentiation | 2 | 2017 | 14 | 0.160 |
Why?
|
| RNA, Messenger | 3 | 2018 | 499 | 0.160 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2019 | 1 | 0.160 |
Why?
|
| Glutamate Decarboxylase | 1 | 2019 | 17 | 0.150 |
Why?
|
| Citalopram | 1 | 2019 | 6 | 0.150 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2019 | 33 | 0.150 |
Why?
|
| Protein Transport | 3 | 2014 | 80 | 0.150 |
Why?
|
| Protein Conformation | 2 | 2017 | 110 | 0.150 |
Why?
|
| Cell Line | 5 | 2010 | 454 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 73 | 0.150 |
Why?
|
| Action Potentials | 3 | 2017 | 212 | 0.140 |
Why?
|
| Photochemical Processes | 1 | 2018 | 1 | 0.140 |
Why?
|
| Synaptic Potentials | 1 | 2017 | 5 | 0.130 |
Why?
|
| Interneurons | 1 | 2017 | 24 | 0.130 |
Why?
|
| Signal Transduction | 4 | 2006 | 727 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2017 | 66 | 0.130 |
Why?
|
| TRPV Cation Channels | 1 | 2017 | 26 | 0.130 |
Why?
|
| Vibration | 1 | 2017 | 10 | 0.130 |
Why?
|
| Electrophysiological Phenomena | 2 | 2013 | 29 | 0.120 |
Why?
|
| Palmitic Acid | 2 | 2006 | 9 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 716 | 0.120 |
Why?
|
| Hippocampus | 1 | 2017 | 216 | 0.120 |
Why?
|
| Cholinergic Agonists | 1 | 2015 | 7 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 42 | 0.110 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2015 | 1 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2006 | 89 | 0.110 |
Why?
|
| Antiparkinson Agents | 1 | 2015 | 10 | 0.110 |
Why?
|
| Levodopa | 1 | 2015 | 15 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2012 | 82 | 0.110 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2014 | 3 | 0.110 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2014 | 7 | 0.110 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2014 | 11 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2015 | 471 | 0.110 |
Why?
|
| Coat Protein Complex I | 1 | 2014 | 1 | 0.100 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2013 | 5 | 0.100 |
Why?
|
| Mecamylamine | 1 | 2013 | 11 | 0.100 |
Why?
|
| Electric Stimulation | 1 | 2014 | 135 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2013 | 28 | 0.100 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 35 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 83 | 0.100 |
Why?
|
| Piperazines | 1 | 2013 | 60 | 0.100 |
Why?
|
| Calcium | 4 | 2019 | 339 | 0.100 |
Why?
|
| Phenotype | 1 | 2015 | 622 | 0.100 |
Why?
|
| Ion Channel Gating | 1 | 2013 | 20 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 186 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 193 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2013 | 299 | 0.100 |
Why?
|
| Fluorescence Resonance Energy Transfer | 2 | 2015 | 8 | 0.100 |
Why?
|
| Nucleus Accumbens | 1 | 2013 | 121 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 69 | 0.090 |
Why?
|
| Pregnancy | 1 | 2015 | 960 | 0.090 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2013 | 147 | 0.090 |
Why?
|
| Exploratory Behavior | 1 | 2011 | 33 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2011 | 136 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2011 | 38 | 0.080 |
Why?
|
| Time Factors | 3 | 2011 | 2203 | 0.080 |
Why?
|
| Prions | 1 | 2010 | 2 | 0.080 |
Why?
|
| Prion Diseases | 1 | 2010 | 3 | 0.080 |
Why?
|
| Ganglionic Stimulants | 1 | 2010 | 6 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 255 | 0.080 |
Why?
|
| Receptors, Dopamine | 1 | 2010 | 26 | 0.080 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2010 | 112 | 0.070 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2008 | 8 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2008 | 23 | 0.070 |
Why?
|
| Transfection | 2 | 2011 | 204 | 0.070 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 1 | 2007 | 5 | 0.070 |
Why?
|
| Second Messenger Systems | 1 | 2007 | 8 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 55 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 83 | 0.060 |
Why?
|
| Humans | 7 | 2019 | 32271 | 0.060 |
Why?
|
| Protein Binding | 3 | 2015 | 244 | 0.060 |
Why?
|
| Hela Cells | 2 | 2003 | 72 | 0.060 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2006 | 1 | 0.060 |
Why?
|
| Xenopus laevis | 1 | 2006 | 4 | 0.060 |
Why?
|
| Nuclear Localization Signals | 1 | 2006 | 4 | 0.060 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2006 | 2 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2006 | 29 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 10 | 0.060 |
Why?
|
| Potassium Channels | 1 | 2005 | 20 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 74 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2019 | 204 | 0.050 |
Why?
|
| RNA Polymerase I | 1 | 2003 | 1 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2003 | 2 | 0.050 |
Why?
|
| Yeasts | 1 | 2003 | 7 | 0.050 |
Why?
|
| Mammals | 1 | 2003 | 14 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 19 | 0.050 |
Why?
|
| Chromatin | 1 | 2003 | 25 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 264 | 0.050 |
Why?
|
| Immunophilins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2002 | 32 | 0.050 |
Why?
|
| Caveolae | 1 | 2001 | 4 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2001 | 8 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2001 | 25 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 32 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2001 | 67 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 71 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 727 | 0.040 |
Why?
|
| Imipramine | 1 | 2019 | 1 | 0.040 |
Why?
|
| Xenopus | 1 | 2019 | 4 | 0.040 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2019 | 6 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 16 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2019 | 43 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 93 | 0.040 |
Why?
|
| Binding Sites | 2 | 2014 | 144 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2018 | 20 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2018 | 32 | 0.030 |
Why?
|
| Capsaicin | 1 | 2017 | 31 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 111 | 0.030 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2017 | 5 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2017 | 10 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 37 | 0.030 |
Why?
|
| Sodium | 1 | 2017 | 41 | 0.030 |
Why?
|
| Microscopy | 1 | 2017 | 28 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 544 | 0.030 |
Why?
|
| Benserazide | 1 | 2015 | 1 | 0.030 |
Why?
|
| Adrenergic Agents | 1 | 2015 | 7 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 49 | 0.030 |
Why?
|
| Oxidopamine | 1 | 2015 | 24 | 0.030 |
Why?
|
| Parkinsonian Disorders | 1 | 2015 | 6 | 0.030 |
Why?
|
| Ganglia, Spinal | 1 | 2015 | 59 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 131 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 25 | 0.030 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 30 | 0.020 |
Why?
|
| Sirolimus | 2 | 2003 | 34 | 0.020 |
Why?
|
| Cocaine | 1 | 2015 | 354 | 0.020 |
Why?
|
| Cyclic AMP | 2 | 2001 | 55 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 74 | 0.020 |
Why?
|
| Ligands | 1 | 2011 | 90 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 1081 | 0.020 |
Why?
|
| Parvalbumins | 1 | 2010 | 10 | 0.020 |
Why?
|
| Gliosis | 1 | 2010 | 5 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2010 | 20 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 120 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 16 | 0.020 |
Why?
|
| Choline | 1 | 2010 | 18 | 0.020 |
Why?
|
| Locus Coeruleus | 1 | 2010 | 23 | 0.020 |
Why?
|
| Serotonin | 1 | 2010 | 44 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2010 | 33 | 0.020 |
Why?
|
| Longevity | 1 | 2010 | 23 | 0.020 |
Why?
|
| Homeostasis | 1 | 2010 | 130 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 9 | 0.020 |
Why?
|
| Body Temperature | 1 | 2010 | 20 | 0.020 |
Why?
|
| Elasticity | 1 | 2010 | 41 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2010 | 58 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2010 | 70 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 79 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2010 | 299 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 12 | 0.020 |
Why?
|
| Lentivirus | 1 | 2007 | 10 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2007 | 81 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2007 | 839 | 0.010 |
Why?
|
| DNA, Ribosomal | 1 | 2003 | 3 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2003 | 43 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2003 | 44 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 112 | 0.010 |
Why?
|
| Cattle | 1 | 2002 | 116 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 250 | 0.010 |
Why?
|
| Nitrobenzenes | 1 | 2001 | 9 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 146 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2001 | 23 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2001 | 36 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2001 | 51 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 138 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 125 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2001 | 77 | 0.010 |
Why?
|
| Base Sequence | 1 | 2001 | 252 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2001 | 86 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 359 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 174 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 408 | 0.010 |
Why?
|
| Rats | 1 | 2001 | 1895 | 0.010 |
Why?
|